Perspective Therapeutics Inc (AMEX: CATX) on Monday, plunged -7.00% from the previous trading day, before settling in for the closing price of $2.57. Within the past 52 weeks, CATX’s price has moved between $1.60 and $16.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -27.61% over the last five years. The company achieved an average annual earnings per share of 7.24%. With a float of $54.06 million, this company’s outstanding shares have now reached $74.05 million.
The firm has a total of 140 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Perspective Therapeutics Inc (CATX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Perspective Therapeutics Inc is 27.18%, while institutional ownership is 66.43%. The most recent insider transaction that took place on Mar 28 ’25, was worth 49,384. In this transaction Chief Executive Officer of this company bought 22,026 shares at a rate of $2.24, taking the stock ownership to the 59,383 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 4,650 for $2.21, making the entire transaction worth $10,288. This insider now owns 4,650 shares in total.
Perspective Therapeutics Inc (CATX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 7.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.62% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Perspective Therapeutics Inc (CATX) is currently performing well based on its current performance indicators. A quick ratio of 17.02 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 120.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.21, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.28 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Analysing the last 5-days average volume posted by the [Perspective Therapeutics Inc, CATX], we can find that recorded value of 0.86 million was better than the volume posted last year of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 36.32%. Additionally, its Average True Range was 0.25.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 29.92%, which indicates a significant decrease from 34.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 125.41% in the past 14 days, which was higher than the 86.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.29, while its 200-day Moving Average is $6.37. Now, the first resistance to watch is $2.62. This is followed by the second major resistance level at $2.85. The third major resistance level sits at $2.99. If the price goes on to break the first support level at $2.25, it is likely to go to the next support level at $2.11. Now, if the price goes above the second support level, the third support stands at $1.88.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
Market capitalization of the company is 177.41 million based on 74,228K outstanding shares. Right now, sales total 1,450 K and income totals -79,280 K. The company made 340 K in profit during its latest quarter, and -18,180 K in sales during its previous quarter.
